Replimune to resubmit twice-rejected drug for approval after FDA shakeup
- Posted on May 29, 2026
- By CNBC
- 0 Views
- 1 min read
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.
